ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,774Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 141

$365K Total Retail Price of All Prescriptions

Rank: 14 out of 141

424 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 424 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

19% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

4% of this provider’s 5,266 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 18%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 377 267 1 2
HYDROCODONE-ACETAMINOPHEN 364 196 S3 2 1
METFORMIN HCL 226 164 3 7
LEVOTHYROXINE SODIUM 189 151 4 4
HYDROCHLOROTHIAZIDE 179 120 5 13
SIMVASTATIN 177 137 6 3
MELOXICAM 173 121 7 16
FUROSEMIDE 160 108 8 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 153 93 9 28
OMEPRAZOLE 142 82 10 6
GABAPENTIN 138 53 11 5
TRAMADOL HCL 135 56 12 20
AMLODIPINE BESYLATE 130 119 13 11
ZOLPIDEM TARTRATE 117 85 14 17
LOVASTATIN 109 77 15 26
RANITIDINE HCL 103 84 16 22
CARVEDILOL 100 62 17 36
METOPROLOL TARTRATE 99 68 18 12
KLOR-CON 8 94 61 19 139
POTASSIUM CHLORIDE 89 51 20 29
AZITHROMYCIN 82 65 21 25
WARFARIN SODIUM 79 69 22 30
CLOPIDOGREL 78 66 23 39
CITALOPRAM HBR 76 61 24 23
PROMETHAZINE HCL 74 50 R 25 34
DICLOFENAC SODIUM 66 36 26 53
LOSARTAN POTASSIUM 66 42 26 48
METFORMIN HCL ER 64 54 28 45
LOSARTAN-HYDROCHLOROTHIAZIDE 58 56 29 82
BISOPROLOL-HYDROCHLOROTHIAZIDE 57 31 30 169
TAMSULOSIN HCL 56 54 31 60
DIGOXIN 56 37 31 88
DILTIAZEM 24HR ER 54 47 33 175
GLYBURIDE 54 38 R 33 52
ATENOLOL 52 35 35 19
ROPINIROLE HCL 52 39 35 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.